🔗 Share this article

An underground economy for unapproved weight-loss drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Popularity Via Social Media

Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these profiles privately for source information, while also obtaining promotional offers.

Active Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Sellers market the substance there before redirecting customers to other platforms for purchases.

Learning About The Experimental Drug

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Experts Voice Worries

However, doctors and chemists have cautions that the sale of what remains an unlicensed medication in the UK is worrisome and could lead to individuals administering substances of uncertain source.

Some experts said the popularity for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach medicines, advertising, and consumer laws, potentially leading to penalties, prosecution or prison.

Platform Response and Content Removal

According to the social media company, the platform has removed problematic content and banned related hashtags and search suggestions. The company said it was committed to maintaining the platform secure and allocating resources in enhancing compliance measures.

Digital Marketplace Activities

Investigations also found communities with up to nine thousand participants marketing the experimental drug using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, populated with photos of slimming results, positive testimonials and step-by-step instructions for preparing or injecting at residence.

After moments of entering one community, a seller shared WhatsApp details, where most purchases take place. The seller sent an guidebook and promised delivery within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about body mass, health issues or previous experience.

Item Information and Costs

Within these groups, messages display black plastic packages with Royal Mail labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, vendors give contradictory answers ranging from a few weeks to “depends on your body”.

Platform Moderation and Safety Actions

A representative for Telegram stated it actively monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering substances they can’t verify. Although the science behind this drug is sound, these digital versions may not include what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in interest to recent price rises for approved slimming medications such as Mounjaro. “With costs rising, patients are using social media. But fake treatments are highly risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.

Her team has already encountered patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These substances could be impure or improperly measured.”

Producer Position

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a Lilly investigational product not yet authorized … may expose users to potentially significant health risks”.